Inactive Instrument

Highlights Vynleads, Inc. Other OTC

Equities

VYND

US92940G1040

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Vynleads, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-22	CI
WG Capital, Ltd acquired 10.8% stake in Vynleads, Inc. from Sergei Stetsenko for $0.01 million.	03-19	CI
Vynleads, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Vynleads, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Vynleads, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/11/22	CI
Vynleads, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22	CI
Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	24/05/22	CI
Vynleads, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
Vynleads, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22/11/21	CI
Vynleads, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	08/10/21	CI
Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	29/06/21	CI
Vynleads, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	07/04/21	CI
Vynleads, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	19/11/20	CI
Sergei Stetsenko, Director, acquired an additional 10.8% stake in Vynleads, Inc. from Stanislav Bezusov, Chief Technology Officer and Director, for $0.01 million.	14/09/20	CI
Vynleads, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	14/08/20	CI
Vynleads, Inc.'s Dwd Protocol & Targeted Nutraceuticals Can Support Type-2 Diabetics Amidst Health Uncertainty	06/07/20	CI
Vynleads, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	29/06/20	CI
Vynleads, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	11/06/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Vynleads, Inc. Other OTC

Equities

VYND

US92940G1040

Highlights

Filters